nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B17—epithelium—thymus cancer	0.0423	0.129	CbGeAlD
Losartan—ACE—pulmonary artery—thymus cancer	0.0377	0.115	CbGeAlD
Losartan—ACE—vein—thymus cancer	0.0343	0.104	CbGeAlD
Losartan—Trauma—Octreotide—thymus cancer	0.0296	0.0441	CcSEcCtD
Losartan—Sinus bradycardia—Octreotide—thymus cancer	0.0287	0.0428	CcSEcCtD
Losartan—Stinging—Octreotide—thymus cancer	0.0174	0.0259	CcSEcCtD
Losartan—Jaundice cholestatic—Octreotide—thymus cancer	0.016	0.0239	CcSEcCtD
Losartan—Cellulitis—Octreotide—thymus cancer	0.0155	0.0231	CcSEcCtD
Losartan—Hyperkalaemia—Octreotide—thymus cancer	0.0138	0.0206	CcSEcCtD
Losartan—SLC2A9—thyroid gland—thymus cancer	0.0131	0.0398	CbGeAlD
Losartan—SLC2A9—lung—thymus cancer	0.0119	0.0362	CbGeAlD
Losartan—Sleep disorder—Octreotide—thymus cancer	0.0118	0.0176	CcSEcCtD
Losartan—Diabetes mellitus—Octreotide—thymus cancer	0.0117	0.0175	CcSEcCtD
Losartan—Nasal congestion—Octreotide—thymus cancer	0.0112	0.0167	CcSEcCtD
Losartan—Injury—Octreotide—thymus cancer	0.0111	0.0166	CcSEcCtD
Losartan—AGTR1—neck—thymus cancer	0.0105	0.032	CbGeAlD
Losartan—Arthritis—Octreotide—thymus cancer	0.0105	0.0157	CcSEcCtD
Losartan—Hypoglycaemia—Octreotide—thymus cancer	0.0105	0.0156	CcSEcCtD
Losartan—Pain in extremity—Octreotide—thymus cancer	0.0102	0.0152	CcSEcCtD
Losartan—SLCO1B3—pituitary gland—thymus cancer	0.0096	0.0292	CbGeAlD
Losartan—Dry skin—Octreotide—thymus cancer	0.00936	0.014	CcSEcCtD
Losartan—Cramp muscle—Octreotide—thymus cancer	0.0092	0.0137	CcSEcCtD
Losartan—Gastritis—Octreotide—thymus cancer	0.00904	0.0135	CcSEcCtD
Losartan—Muscular weakness—Octreotide—thymus cancer	0.00901	0.0134	CcSEcCtD
Losartan—UGT1A1—hematopoietic system—thymus cancer	0.009	0.0273	CbGeAlD
Losartan—Influenza—Octreotide—thymus cancer	0.00883	0.0132	CcSEcCtD
Losartan—Pancreatitis—Octreotide—thymus cancer	0.00866	0.0129	CcSEcCtD
Losartan—Bronchitis—Octreotide—thymus cancer	0.00849	0.0127	CcSEcCtD
Losartan—Upper respiratory tract infection—Octreotide—thymus cancer	0.00821	0.0122	CcSEcCtD
Losartan—Pollakiuria—Octreotide—thymus cancer	0.00816	0.0122	CcSEcCtD
Losartan—SLC2A9—lymph node—thymus cancer	0.00814	0.0247	CbGeAlD
Losartan—Weight increased—Octreotide—thymus cancer	0.00803	0.012	CcSEcCtD
Losartan—Hyperglycaemia—Octreotide—thymus cancer	0.00796	0.0119	CcSEcCtD
Losartan—Pneumonia—Octreotide—thymus cancer	0.00792	0.0118	CcSEcCtD
Losartan—AGTR1—hematopoietic system—thymus cancer	0.00785	0.0239	CbGeAlD
Losartan—ACE—neck—thymus cancer	0.00779	0.0237	CbGeAlD
Losartan—Neuropathy peripheral—Octreotide—thymus cancer	0.00772	0.0115	CcSEcCtD
Losartan—Jaundice—Octreotide—thymus cancer	0.00767	0.0114	CcSEcCtD
Losartan—Conjunctivitis—Octreotide—thymus cancer	0.00765	0.0114	CcSEcCtD
Losartan—Urinary tract infection—Octreotide—thymus cancer	0.00765	0.0114	CcSEcCtD
Losartan—SLCO1B3—lung—thymus cancer	0.00752	0.0228	CbGeAlD
Losartan—SLCO1B1—hematopoietic system—thymus cancer	0.00749	0.0227	CbGeAlD
Losartan—Epistaxis—Octreotide—thymus cancer	0.00742	0.0111	CcSEcCtD
Losartan—Sinusitis—Octreotide—thymus cancer	0.00739	0.011	CcSEcCtD
Losartan—AGTR1—epithelium—thymus cancer	0.00718	0.0218	CbGeAlD
Losartan—Rhinitis—Octreotide—thymus cancer	0.00708	0.0106	CcSEcCtD
Losartan—Hepatitis—Octreotide—thymus cancer	0.00707	0.0105	CcSEcCtD
Losartan—Hypoaesthesia—Octreotide—thymus cancer	0.00703	0.0105	CcSEcCtD
Losartan—Pharyngitis—Octreotide—thymus cancer	0.00701	0.0105	CcSEcCtD
Losartan—Tinnitus—Octreotide—thymus cancer	0.00659	0.00982	CcSEcCtD
Losartan—Flushing—Octreotide—thymus cancer	0.00656	0.00978	CcSEcCtD
Losartan—Arrhythmia—Octreotide—thymus cancer	0.00631	0.00941	CcSEcCtD
Losartan—Alopecia—Octreotide—thymus cancer	0.00624	0.00931	CcSEcCtD
Losartan—Erythema—Octreotide—thymus cancer	0.00615	0.00917	CcSEcCtD
Losartan—Flatulence—Octreotide—thymus cancer	0.00606	0.00904	CcSEcCtD
Losartan—Tension—Octreotide—thymus cancer	0.00604	0.009	CcSEcCtD
Losartan—Nervousness—Octreotide—thymus cancer	0.00597	0.00891	CcSEcCtD
Losartan—AGTR1—cardiac atrium—thymus cancer	0.00596	0.0181	CbGeAlD
Losartan—Back pain—Octreotide—thymus cancer	0.00595	0.00887	CcSEcCtD
Losartan—Muscle spasms—Octreotide—thymus cancer	0.00591	0.00882	CcSEcCtD
Losartan—AGTR1—pituitary gland—thymus cancer	0.00582	0.0177	CbGeAlD
Losartan—Vision blurred—Octreotide—thymus cancer	0.0058	0.00864	CcSEcCtD
Losartan—ACE—hematopoietic system—thymus cancer	0.0058	0.0176	CbGeAlD
Losartan—Tremor—Octreotide—thymus cancer	0.00576	0.00859	CcSEcCtD
Losartan—Ill-defined disorder—Octreotide—thymus cancer	0.00571	0.00851	CcSEcCtD
Losartan—Anaemia—Octreotide—thymus cancer	0.00569	0.00848	CcSEcCtD
Losartan—Agitation—Octreotide—thymus cancer	0.00565	0.00843	CcSEcCtD
Losartan—Malaise—Octreotide—thymus cancer	0.00555	0.00827	CcSEcCtD
Losartan—AGTR1—lymphoid tissue—thymus cancer	0.00553	0.0168	CbGeAlD
Losartan—Vertigo—Octreotide—thymus cancer	0.00553	0.00824	CcSEcCtD
Losartan—Syncope—Octreotide—thymus cancer	0.00552	0.00822	CcSEcCtD
Losartan—Palpitations—Octreotide—thymus cancer	0.00544	0.0081	CcSEcCtD
Losartan—Loss of consciousness—Octreotide—thymus cancer	0.00541	0.00806	CcSEcCtD
Losartan—Cough—Octreotide—thymus cancer	0.00537	0.008	CcSEcCtD
Losartan—ACE—epithelium—thymus cancer	0.0053	0.0161	CbGeAlD
Losartan—Arthralgia—Octreotide—thymus cancer	0.00524	0.00781	CcSEcCtD
Losartan—Myalgia—Octreotide—thymus cancer	0.00524	0.00781	CcSEcCtD
Losartan—Chest pain—Octreotide—thymus cancer	0.00524	0.00781	CcSEcCtD
Losartan—Anxiety—Octreotide—thymus cancer	0.00522	0.00778	CcSEcCtD
Losartan—Discomfort—Octreotide—thymus cancer	0.00517	0.00771	CcSEcCtD
Losartan—Dry mouth—Octreotide—thymus cancer	0.00512	0.00763	CcSEcCtD
Losartan—AGTR1—thyroid gland—thymus cancer	0.00502	0.0153	CbGeAlD
Losartan—Oedema—Octreotide—thymus cancer	0.00502	0.00748	CcSEcCtD
Losartan—Anaphylactic shock—Octreotide—thymus cancer	0.00502	0.00748	CcSEcCtD
Losartan—Infection—Octreotide—thymus cancer	0.00499	0.00743	CcSEcCtD
Losartan—Shock—Octreotide—thymus cancer	0.00494	0.00736	CcSEcCtD
Losartan—Nervous system disorder—Octreotide—thymus cancer	0.00492	0.00734	CcSEcCtD
Losartan—Thrombocytopenia—Octreotide—thymus cancer	0.00492	0.00733	CcSEcCtD
Losartan—Tachycardia—Octreotide—thymus cancer	0.0049	0.0073	CcSEcCtD
Losartan—CYP2C19—hematopoietic system—thymus cancer	0.00488	0.0148	CbGeAlD
Losartan—Hyperhidrosis—Octreotide—thymus cancer	0.00485	0.00723	CcSEcCtD
Losartan—Anorexia—Octreotide—thymus cancer	0.00479	0.00713	CcSEcCtD
Losartan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00457	0.00682	CcSEcCtD
Losartan—AGTR1—lung—thymus cancer	0.00456	0.0139	CbGeAlD
Losartan—Insomnia—Octreotide—thymus cancer	0.00454	0.00677	CcSEcCtD
Losartan—Paraesthesia—Octreotide—thymus cancer	0.00451	0.00672	CcSEcCtD
Losartan—Dyspnoea—Octreotide—thymus cancer	0.00448	0.00667	CcSEcCtD
Losartan—Somnolence—Octreotide—thymus cancer	0.00446	0.00665	CcSEcCtD
Losartan—Dyspepsia—Octreotide—thymus cancer	0.00442	0.00659	CcSEcCtD
Losartan—ACE—cardiac atrium—thymus cancer	0.0044	0.0134	CbGeAlD
Losartan—Decreased appetite—Octreotide—thymus cancer	0.00436	0.00651	CcSEcCtD
Losartan—Fatigue—Octreotide—thymus cancer	0.00433	0.00645	CcSEcCtD
Losartan—ACE—pituitary gland—thymus cancer	0.0043	0.0131	CbGeAlD
Losartan—Constipation—Octreotide—thymus cancer	0.00429	0.0064	CcSEcCtD
Losartan—Pain—Octreotide—thymus cancer	0.00429	0.0064	CcSEcCtD
Losartan—CYP2C8—hematopoietic system—thymus cancer	0.00426	0.0129	CbGeAlD
Losartan—Feeling abnormal—Octreotide—thymus cancer	0.00414	0.00617	CcSEcCtD
Losartan—Gastrointestinal pain—Octreotide—thymus cancer	0.00411	0.00612	CcSEcCtD
Losartan—ACE—lymphoid tissue—thymus cancer	0.00408	0.0124	CbGeAlD
Losartan—Urticaria—Octreotide—thymus cancer	0.00399	0.00595	CcSEcCtD
Losartan—CYP1A2—hematopoietic system—thymus cancer	0.00398	0.0121	CbGeAlD
Losartan—Abdominal pain—Octreotide—thymus cancer	0.00397	0.00592	CcSEcCtD
Losartan—Body temperature increased—Octreotide—thymus cancer	0.00397	0.00592	CcSEcCtD
Losartan—CYP3A5—hematopoietic system—thymus cancer	0.00384	0.0117	CbGeAlD
Losartan—CYP2C9—hematopoietic system—thymus cancer	0.00378	0.0115	CbGeAlD
Losartan—ACE—bone marrow—thymus cancer	0.00372	0.0113	CbGeAlD
Losartan—ACE—thyroid gland—thymus cancer	0.00371	0.0113	CbGeAlD
Losartan—Hypersensitivity—Octreotide—thymus cancer	0.0037	0.00551	CcSEcCtD
Losartan—Asthenia—Octreotide—thymus cancer	0.0036	0.00537	CcSEcCtD
Losartan—Pruritus—Octreotide—thymus cancer	0.00355	0.00529	CcSEcCtD
Losartan—Diarrhoea—Octreotide—thymus cancer	0.00344	0.00512	CcSEcCtD
Losartan—ACE—lung—thymus cancer	0.00337	0.0102	CbGeAlD
Losartan—Dizziness—Octreotide—thymus cancer	0.00332	0.00495	CcSEcCtD
Losartan—Vomiting—Octreotide—thymus cancer	0.00319	0.00476	CcSEcCtD
Losartan—Rash—Octreotide—thymus cancer	0.00317	0.00472	CcSEcCtD
Losartan—Dermatitis—Octreotide—thymus cancer	0.00316	0.00471	CcSEcCtD
Losartan—CYP2C8—pituitary gland—thymus cancer	0.00316	0.00959	CbGeAlD
Losartan—Headache—Octreotide—thymus cancer	0.00315	0.00469	CcSEcCtD
Losartan—AGTR1—lymph node—thymus cancer	0.00312	0.00948	CbGeAlD
Losartan—Nausea—Octreotide—thymus cancer	0.00298	0.00445	CcSEcCtD
Losartan—CYP3A4—hematopoietic system—thymus cancer	0.00288	0.00876	CbGeAlD
Losartan—CYP1A2—thyroid gland—thymus cancer	0.00255	0.00774	CbGeAlD
Losartan—ALB—lymph node—thymus cancer	0.00241	0.00731	CbGeAlD
Losartan—CYP1A2—lung—thymus cancer	0.00231	0.00703	CbGeAlD
Losartan—ACE—lymph node—thymus cancer	0.0023	0.007	CbGeAlD
Losartan—CYP3A5—lung—thymus cancer	0.00223	0.00678	CbGeAlD
Losartan—ABCB1—hematopoietic system—thymus cancer	0.00204	0.0062	CbGeAlD
Losartan—ABCB1—epithelium—thymus cancer	0.00187	0.00567	CbGeAlD
Losartan—ABCB1—pituitary gland—thymus cancer	0.00151	0.0046	CbGeAlD
Losartan—ABCB1—lymphoid tissue—thymus cancer	0.00144	0.00437	CbGeAlD
Losartan—ABCB1—bone marrow—thymus cancer	0.00131	0.00398	CbGeAlD
Losartan—ABCB1—thyroid gland—thymus cancer	0.00131	0.00397	CbGeAlD
Losartan—ABCB1—lung—thymus cancer	0.00119	0.0036	CbGeAlD
Losartan—ABCB1—lymph node—thymus cancer	0.000811	0.00246	CbGeAlD
